Discover Negotiate Pair (DNP) Development

Standard software allowing true plug and play of unit op components, reducing automation changes from months to days.
Categories
Proteins/ Antibodies

Industry Need

Automation changes take weeks to months, often on critical path for tech transfer.

Approach

Standard and software allowing true plug and play of unit op components.

Impacts

Reduce reconfiguration downtime from months to days (assume 4 wks savings).

Value Statement/Outcomes

By implementing Device Network Protocol (DNP) for standardized, plug-and-play device integration, an organization could reduce reconfiguration downtime by an estimated 4 weeks per change, enabling faster technology transfer, lower validation costs, and increased operational flexibility for future-proof biomanufacturing.

Outputs/Deliverables

Interchangeability Demonstrations- SMART O2 sensors from different vendors used to connect to same HMI using the DNP / MTP automation platform while in-process (Complete December 7, 2021). Videos/recordings available upon request.

Demonstration 1: March 2021. MTP Connectivity using a smart pump Demonstration 2: June 2021. Interchangeability with 1 smart sensor Demonstration 3: July 2021. Interchangeability with 2 smart sensors Beta Demonstration: December 2021. Demonstrate MTP connectivity and interchangeability between 2 smart sensors

Reconfigurability Demonstrations- added new processing capability (glucose control) during pre-process equipment setup without re-programming the HMI and process orchestration layer (Complete July 11, 2023). Videos/recordings available upon request.

Demonstration 1: June 2022. POL augmented with 1 smart actuator and 1 smart sensor. Demonstration 2: November 2022. Extend existing MTP service to smart actuator. Demonstration 3: July 2023. Adding new MTP service. DNP Workshop. March 27th, 2024 in France.

Posters

Randolph, P., Rode, C., Polilli, B., Fejoz, L., Reinbigler, R., Phillips, M., Hart, R., Erickson, J., & Kaneshiro, S. Participant, ICB, Bringing Flexibility to Integrated Continuous Biomanufacturing. Poster presentation, October 12, 2022.

Presentations

Fejoz, L., Presenter, Plug-n-Play Session, NIIMBL National Meeting, Washington, D.C., July 15, 2021.

Fejoz, L., Reinbigler, R. Presenters. Process Intensification Flexibility Workstream: Software and Data, NIIMBL National Meeting, Washington, DC, June 29, 2023.

Tung, G., Presenter, An Approach to Computer System Validation for NIIMBL DNP, NIIMBL National Meeting, Washington, DC, June 24, 2025.

Additional Project Information (Members Only)

Login to the NIIMBL member portal to access additional project information, including presentations, progress updates, reports, and more.

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Participating Organizations

Amgen Inc.

Amgen Inc.

Bristol-Myers Squibb

Bristol-Myers Squibb

CSL Behring, LLC

CSL Behring, LLC

Cytiva

Cytiva

EMD Millipore Corporation

EMD Millipore Corporation

Eli Lilly and Company

Eli Lilly and Company

Emerson Automation Solutions

Emerson Automation Solutions

GlaxoSmithKline, LLC

GlaxoSmithKline, LLC

Janssen Research & Development, LLC

Janssen Research & Development, LLC

Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC

Pfizer, Inc.

Pfizer, Inc.

Sanofi

Sanofi

Sartorius Stedim

Sartorius Stedim